Financials Kamada Ltd.

Equities

KMDA

IL0010941198

Pharmaceuticals

Market Closed - TEL AVIV STOCK EXCHANGE 07:24:09 2024-04-25 am EDT 5-day change 1st Jan Change
1,938 ILa -2.42% Intraday chart for Kamada Ltd. +0.31% -12.98%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 960.1 924.6 920.4 615 1,280 1,114 - -
Enterprise Value (EV) 1 960.1 924.6 920.4 615 1,280 1,114 1,114 1,114
P/E ratio - - - - - - - -
Yield - - - - - - - -
Capitalization / Revenue 2.2 x 2.13 x 2.7 x 1.31 x 2.51 x 1.94 x 1.58 x 1.41 x
EV / Revenue 2.2 x 2.13 x 2.7 x 1.31 x 2.51 x 1.94 x 1.58 x 1.41 x
EV / EBITDA - - - - 14,821,198 x - - -
EV / FCF 11.5 x 22.5 x -22.1 x - -233 x 17.4 x 8.43 x 7.16 x
FCF Yield 8.72% 4.44% -4.52% - -0.43% 5.75% 11.9% 14%
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 40,512 44,731 44,786 44,826 57,476 57,480 - -
Reference price 2 23.70 20.67 20.55 13.72 22.27 19.38 19.38 19.38
Announcement Date 2/12/20 2/10/21 3/15/22 3/15/23 3/6/24 - - -
1ILS in Million2
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 436.2 433.1 340.3 469.1 510.9 573.4 706 787.8
EBITDA - - - - 86.36 - - -
EBIT 1 78.14 62.53 -2.286 16.44 36.08 56.88 103.2 124.7
Operating Margin 17.91% 14.44% -0.67% 3.5% 7.06% 9.92% 14.62% 15.83%
Earnings before Tax (EBT) 1 78.81 60.35 -6.19 -8.192 30.22 53.82 99.74 120.8
Net income 1 76.31 55.72 -7.323 -8.417 29.7 46.19 84 102.4
Net margin 17.49% 12.86% -2.15% -1.79% 5.81% 8.06% 11.9% 13%
EPS - - - - - - - -
Free Cash Flow 1 83.7 41.06 -41.62 - -5.499 64.02 132.1 155.6
FCF margin 19.19% 9.48% -12.23% - -1.08% 11.17% 18.71% 19.75%
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) 109.69% 73.69% - - - 138.6% 157.28% 151.92%
Dividend per Share - - - - - - - -
Announcement Date 2/12/20 2/10/21 3/15/22 3/15/23 3/6/24 - - -
1ILS in Million
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 71.3 103.3 95.31 76.9 111.8 164.8 113.6 140.1 146.1 130.6 137.8 142.7 145.7 147.2
EBITDA 1.764 - - - - - - - - - - - - -
EBIT 1 -2.489 -10.84 0.8346 -7.478 8.893 14.57 1.069 9.846 16.82 9.951 14.74 15.35 15.13 12.04
Operating Margin -3.49% -10.49% 0.88% -9.72% 7.95% 8.84% 0.94% 7.03% 11.51% 7.62% 10.7% 10.76% 10.38% 8.18%
Earnings before Tax (EBT) 1 -2.616 -15.32 -6.063 -12.75 1.715 10.68 -6.641 7.129 12.69 18.01 14.01 14.61 14.36 11.28
Net income 1 -2.616 -16.45 -6.202 -12.78 1.68 10.68 -6.689 6.781 12.41 18.13 12.04 12.52 12.26 9.553
Net margin -3.67% -15.92% -6.51% -16.62% 1.5% 6.48% -5.89% 4.84% 8.5% 13.88% 8.74% 8.77% 8.42% 6.49%
EPS - - - - - - - - - - - - - -
Dividend per Share - - - - - - - - - - - - - -
Announcement Date 11/22/21 3/15/22 5/17/22 8/17/22 11/22/22 3/15/23 5/24/23 8/16/23 11/13/23 3/6/24 - - - -
1ILS in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 83.7 41.1 -41.6 - -5.5 64 132 156
ROE (net income / shareholders' equity) - - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex 1 7.89 17.9 12.2 13.7 21 1.74 1.39 1.11
Capex / Sales 1.81% 4.12% 3.59% 2.93% 4.1% 0.3% 0.2% 0.14%
Announcement Date 2/12/20 2/10/21 3/15/22 3/15/23 3/6/24 - - -
1ILS in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Equities
  3. KMDA Stock
  4. Financials Kamada Ltd.